Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Medicus Pharma Ltd (MDCX : NSDQ)

• Company Description    Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario. Number of Employees: 16

• Price / Volume Information    Yesterday's Closing Price: $0.30 Daily Weekly Monthly 20 Day Moving Average: 2,042,671 shares Shares Outstanding: 56.66 (millions) Market Capitalization: $17.00 (millions) Beta: -0.47 52 Week High: $7.73 52 Week Low: $0.25 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -9.67% -14.08% 12 Week -77.94% -79.61% Year To Date -80.39% -82.81%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 CONSHOHOCKEN STATE RD. SUITE 200 - W. CONSHOHOCKEN,PA 19428 USA ph: 610-636-0184 fax: - ir@medicuspharma.com https://medicuspharma.com

• General Corporate Information    Officers Raza Bokhari - Chief Executive Officer and Executive Chairman Carolyn Bonner - President and Chief Financial Officer Larry Kaiser - Director Robert J. Ciaruffoli - Director William L. Ashton - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 58471K202 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/10/26 Share - Related Items Shares Outstanding: 56.66 Most Recent Split Date: (:1) Beta: -0.47 Market Capitalization: $17.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.56 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 11.90 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 26.19% vs. Previous Quarter: 62.20% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -3,137.84 12/31/25 - -2,309.37 09/30/25 - -1,077.62 ROA 03/31/26 - -311.33 12/31/25 - -284.09 09/30/25 - -250.67 Current Ratio 03/31/26 - 1.22 12/31/25 - 1.00 09/30/25 - 0.92 Quick Ratio 03/31/26 - 1.22 12/31/25 - 1.00 09/30/25 - 0.92 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 0.03 12/31/25 - 0.00 09/30/25 - -0.05 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - - Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - -

Powered by Zacks Investment Research ©